4-((1S,3S)-3-Hydroxycyclohexylamino)-2-((trans)-4-methoxycyclo-hexylamino)pyrimidine-5-carboxamide

ID: ALA4848796

Chembl Id: CHEMBL4848796

PubChem CID: 71237490

Max Phase: Preclinical

Molecular Formula: C18H29N5O3

Molecular Weight: 363.46

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CO[C@H]1CC[C@H](Nc2ncc(C(N)=O)c(N[C@H]3CCC[C@H](O)C3)n2)CC1

Standard InChI:  InChI=1S/C18H29N5O3/c1-26-14-7-5-11(6-8-14)22-18-20-10-15(16(19)25)17(23-18)21-12-3-2-4-13(24)9-12/h10-14,24H,2-9H2,1H3,(H2,19,25)(H2,20,21,22,23)/t11-,12-,13-,14-/m0/s1

Standard InChI Key:  DNQLQDZACRVRIW-XUXIUFHCSA-N

Associated Targets(Human)

MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK9 Tchem c-Jun N-terminal kinase 2 (4655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mapk8 Mitogen-activated protein kinase 8 (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.46Molecular Weight (Monoisotopic): 363.2270AlogP: 1.66#Rotatable Bonds: 6
Polar Surface Area: 122.39Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.55CX Basic pKa: 5.79CX LogP: 1.16CX LogD: 1.15
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.61Np Likeness Score: -0.41

References

1. Nagy MA, Hilgraf R, Mortensen DS, Elsner J, Norris S, Tikhe J, Yoon W, Paisner D, Delgado M, Erdman P, Haelewyn J, Khambatta G, Xu L, Romanow WJ, Condroski K, Bahmanyar S, McCarrick M, Benish B, Blease K, LeBrun L, Moghaddam MF, Apuy J, Canan SS, Bennett BL, Satoh Y..  (2021)  Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001.,  64  (24.0): [PMID:34894681] [10.1021/acs.jmedchem.1c01716]

Source